1. Of the judgment of the court of first instance, the part against the defendant in excess of the amount ordered to be paid below shall be cancelled.

. 1. 1. Hanmun-si 7,483 1,578 1,274 1,508 1,610 13,454 913 193 155 196 1,642

2. Han-gluoride 722 480 1,204 103 68171

3. Other 10cm 544,37 487,455 377,132321,853 273,962 2,004,75297,414 87,340,69257,727 49,348;

4. treatment-based 10 gresponding 10 gresponding 157,983 145,037 156,208 121,884 112,821 693,947 29,080 26,707 28,832,537 20,855 128,011 5 gresponding 66,544 71,579 70,189 65,839 21,856 296,012,57 13,528 12,464,444,55,946

6. Magyphos 499,135 462,408 470,47346,521 218,599 1,97,142 95,802 88,726 89,816,151 41,726 382,221

7. Fluorgium 612,685 583,118 445,034 397,231 40,389 2,438,464 122,333 16,254 88,359 78,529 79, 484,579,579;

8. Dextrins 1,595,410 1,338,801,347,020 1,212,739 1,104,4516,598,429 757,995 633,267,637,048 573,6322,349 3,124,291;

9. Tsch Rexroth 10 g 94,418 105,726 168,077 170,702 245,208 784,150 45,193 50,620 79,017 79,916 114,214 368,960 total sales volume 14,827,54 sales volume 4,905,169* sales volume (unit: unit) and the lower part is sales amount (unit: 2,000 won).

㈐ 따라서, 원고가 입은 손해는 아래와 같이 계산된다.

1) Where another pharmaceutical product of the same pharmaceutical product has been sold in the same quantity during the same period (46 won-30 won) x 20 x 198 x (479 won-330 won) x 3,047,079 x 454,079,195 x 454,079,73,05 won x 454,079,195 x 454,079,195 x 403,5 x 403,55 x 403,55 x 403,555 x 403,555 x 403,555,46 (3) x 198 x (47,330 won) x 3,09 x 454,000 won x 1,459,73,005 won.